WeVote
Log In

Bill

Bill

S 11

Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities

2025 Regular Session Introduced by Nathalia Fernández and 2 co-sponsors

Bill S 11 mandates healthcare providers to disclose vital information about non-invasive prenatal screenings, empowering expectant parents to make informed decisions.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 11

Summary of Bill S 11

Bill Overview

  • Bill Number: S 11
  • Title: Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities
  • Status: Referred to Health Committee
  • Introduced: January 08, 2025
  • Classification: Legislative Bill

Purpose and Intent

The primary purpose of Bill S 11 is to mandate the disclosure of comprehensive information regarding non-invasive prenatal screening (NIPS) tests for chromosomal abnormalities. The bill aims to ensure that expectant parents receive adequate information about the benefits, limitations, and potential implications of these screenings, thereby promoting informed decision-making in prenatal care.

Key Provisions

  • Mandatory Disclosure: Healthcare providers must provide clear and accessible information about NIPS tests, including:

    • The types of chromosomal abnormalities that can be detected.
    • The accuracy and reliability of the tests.
    • Potential false positives and negatives.
    • The implications of test results for the pregnancy and the child.

  • Informed Consent: The bill emphasizes the necessity of obtaining informed consent from patients before conducting NIPS tests, ensuring that parents are fully aware of what the tests entail.

  • Educational Resources: The bill may require healthcare facilities to offer educational materials or resources that explain the NIPS process and its significance in prenatal care.

Affected Parties

  • Expectant Parents: The primary beneficiaries of this bill are expectant parents who will have access to vital information that can influence their prenatal decisions.
  • Healthcare Providers: Medical professionals will need to comply with the new disclosure requirements, which may involve additional training or resource allocation.
  • Healthcare Facilities: Hospitals and clinics may need to develop or enhance educational programs and materials related to NIPS.

Legislative Timeline

  • January 08, 2025: Bill introduced and referred to the Health Committee.
  • February 04, 2025: First report calendar (CAL.269).
  • February 05, 2025: Second report calendar.
  • February 10, 2025: Advanced to third reading.
  • March 03, 2025: Passed in the Senate and delivered to the Assembly.
  • March 03, 2025: Referred to the Assembly Health Committee.

Related Legislation

  • S 8286: A prior-session bill that may have addressed similar issues.
  • S 1159: Another prior-session bill related to prenatal screening.
  • A 44: A companion bill in the Assembly that aligns with the objectives of S 11.

Conclusion

Bill S 11 seeks to enhance the transparency and understanding of non-invasive prenatal screening for chromosomal abnormalities. By requiring healthcare providers to disclose critical information, the bill aims to empower expectant parents with the knowledge necessary to make informed choices regarding their prenatal care. The bill is currently under consideration in the Assembly Health Committee following its passage in the Senate.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.